Tech Company Financing Transactions

Edimer Pharmaceuticals Funding Round

Edimer Pharmaceuticals, based in Cambridge, secured $18 million in investment from New Enterprise Associates, Sanofi-Genzyme BioVentures and Third Rock Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

55 Cambridge Pkwy. 102W
Cambridge, MA 02142
USA

Phone

617-758-4300

Website

www.edimerpharma.com

Email Address

[email protected]

Overview

Edimer is dedicated to developing EDI200 as a treatment for X-linked Hypohidrodic Ectodermal Dysplasia (XLHED). Learn more edimerpharma.com and XLHEDnetwork.com

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Neil Kirby

        

VP - Operations

Ramsey Johnson

        

Browse more venture capital transactions:

Prev: 7/30/2013: Rover.com venture capital transaction
Next: 7/31/2013: 4INFO venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to record funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary